The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Carmine Bryce D. since 2010.
The trader's CIK number is 1430788.
At the time of the last reporting, Carmine Bryce D. was the EVP and Pres, Est Markets BU of Eli Lilly & Co. (stock ticker symbol LLY).
Also see all insider trading activities at Eli Lilly & Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | LLY | 0 | $0 | 0 | $0 | 87,924 | $0 |
| 2011 | LLY | 0 | $0 | 57,587 | $2,117,711 | 82,942 | $0 |
| 2010 | LLY | 0 | $0 | 15,500 | $551,985 | 51,249 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-02-01 | LLY | Option Ex | 87,924 | .00 | 0 |
| 2011-12-12 | LLY | Sale | 5,787 | 39.10 | 226,271 |
| 2011-11-11 | LLY | Sale | 5,700 | 37.55 | 214,034 |
| 2011-10-11 | LLY | Sale | 5,700 | 38.10 | 217,170 |
| 2011-09-12 | LLY | Sale | 5,700 | 35.91 | 204,686 |
| 2011-08-11 | LLY | Sale | 5,700 | 33.94 | 193,458 |
| 2011-07-11 | LLY | Sale | 5,700 | 37.39 | 213,123 |
| 2011-06-13 | LLY | Sale | 5,700 | 37.25 | 212,325 |
| 2011-05-11 | LLY | Sale | 5,700 | 38.21 | 217,797 |
| 2011-04-11 | LLY | Sale | 5,700 | 35.76 | 203,832 |
| 2011-02-16 | LLY | Sale | 3,100 | 34.49 | 106,919 |
| 2011-02-01 | LLY | Option Ex | 82,942 | .00 | 0 |
| 2011-01-14 | LLY | Sale | 3,100 | 34.87 | 108,096 |
| 2010-12-16 | LLY | Sale | 3,100 | 35.10 | 108,810 |
| 2010-11-16 | LLY | Sale | 3,100 | 34.43 | 106,733 |
| 2010-10-15 | LLY | Sale | 3,100 | 37.65 | 116,715 |
| 2010-09-16 | LLY | Sale | 3,100 | 35.55 | 110,204 |
| 2010-08-16 | LLY | Sale | 3,100 | 35.33 | 109,523 |
| 2010-02-01 | LLY | Option Ex | 51,249 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Carmine Bryce D. (EVP and Pres, Est Markets BU of Eli Lilly & Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.